LTβR expression on hematopoietic cells regulates acute inflammation and influences maturation of myeloid subpopulations.
Lymphotoxin beta-receptor (LTβR) is involved in the formation and maintenance of secondary lymphoid structures, as well as in the regulation of inflammatory responses. Because LTβR lymphoid structure formation continues to develop in infants, we compared two different chimera models: one using adult mice and the other using a transplantation model of neonatal mice. To elucidate the function of LTβR on lymphoid and non-lymphoid cells, we generated bone marrow chimeras on the wild type C57Bl/6 and the LTβR-deficient (LTβR(-/-)) background, and reconstituted the mice with bone marrow cells reciprocally. These chimeric mice were analyzed in the experimental model of acute dextran sulfate sodium-induced colitis. Interestingly, both models revealed not only equal reconstitution levels but also similar immunological responses: LTβR expression on stromal cells is essential for lymph node formation, whereas LTBR on hematopoietic cells is crucial for a decrease in inflammation. In addition, mice lacking LTβR on hematopoietic cells revealed (a) an increase of immature granulocytic cells in the spleen and (b) a reduced proportion of myeloid cells in peripheral blood and spleen expressing CD11b(+)Ly6C(+)Ly6G(-) (myeloid-derived suppressor cells expression profile). In conclusion, LTβR expression on hematopoietic cells seems to be involved in the down-regulation of acute inflammatory reactions paralleled by the appearance of immature myeloid cells.
Institute of Immunology, University of Regensburg, Regensburg, Germany Clinic of Gynecology and Obstetrics, Caritas Hospital St. Josef, University of Regensburg, Regensburg, Germany Anja.Wege@klinik.uni-regensburg.de.
Anja K
AK
Wege
Institute of Immunology, University of Regensburg, Regensburg, Germany.
Barbara
B
Huber
Institute of Immunology, University of Regensburg, Regensburg, Germany.
Nadin
N
Wimmer
Institute of Immunology, University of Regensburg, Regensburg, Germany.
Daniela N
DN
Männel
Institute of Immunology, University of Regensburg, Regensburg, Germany.
Thomas
T
Hehlgans
D000818:Animals; D000831:Animals, Newborn; D001854:Bone Marrow Cells / Q000378:metabolism; D039481:CD11b Antigen / Q000378:metabolism; D049109:Cell Proliferation; D003092:Colitis / Q000139:chemically induced / Q000378:metabolism; D006098:Granulocytes / Q000378:metabolism; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D007249:Inflammation / Q000473:pathology*; D008221:Lymphoid Tissue / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D053259:Lymphotoxin beta Receptor / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D050506:Mutant Chimeric Proteins / Q000235:genetics; D022423:Myeloid Cells / Q000502:physiology*; D013154:Spleen / Q000166:cytology / Q000254:growth & development
D039481:CD11b Antigen; C505699:Ltbr protein, mouse; D053259:Lymphotoxin beta Receptor; D050506:Mutant Chimeric Proteins
Bone marrow chimera; DSS-induced colitis; LTβR; MDSC; dampening inflammation